Topic
Evidence Critique
Where the popular health-science narrative breaks. Keto trials and their retractions, the LMHR hypothesis, supplement marketing, and the difference between mechanism and outcome data.
4 articles
The Longevity Compound Promoted on Half a Mechanism
Its entire case for your heart is one biochemical arrow. I followed the other one, the one that runs the wrong way, and as a guy with a stent I walked away.
The Gut May Be the Point: Metformin, Citrulline, and the Exercise Question
A new Nature Metabolism paper places metformin's main effect in the gut, not muscle. That eases one exercise-blunting fear and raises a sharper one: citrulline and nitric oxide.
I Was “Metabolically Healthy.” I Got a Stent at 44 Anyway.
Low hsCRP, a flat CGM, no insulin resistance: every marker the low-carb world calls “safe.” Then a CT angiogram found an 80% blockage in my right coronary artery.
The Study the Keto Community Uses to Say LDL Doesn’t Matter. Then the Follow-Up Got Retracted.
A keto study is cited to argue high LDL is harmless when metabolic markers are clean. The follow-up that measured soft plaque was retracted in 2026. Here's what the evidence shows.